Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;4(2):144-152.
doi: 10.1016/j.jpha.2013.05.003. Epub 2013 Jun 19.

Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC-MS/MS and its application in bioequivalence studies

Bhupinder Singh  1 , Rama S Lokhandae  2 , Ashish Dwivedi  1 , Sandeep Sharma  1 , Naveen Dubey  1
Affiliations

Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC-MS/MS and its application in bioequivalence studies

Bhupinder Singh et al. J Pharm Anal. 2014 Apr.

Abstract

A validated ultra-performance liquid chromatography mass spectrometric method (UPLC-MS/MS) was used for the simultaneous quantitation of candesartan (CN) and hydrochlorothiazide (HCT) in human plasma. The analysis was performed on UPLC-MS/MS system using turbo ion spray interface. Negative ions were measured in multiple reaction monitoring (MRM) mode. The analytes were extracted using a liquid-liquid extraction (LLE) method by using 0.1 mL of plasma volume. The lower limit of quantitation for CN and HCT was 1.00 ng/mL whereas the upper limit of quantitation was 499.15 ng/mL and 601.61 ng/mL for CN and HCT respectively. CN d4 and HCT-13Cd2 were used as the internal standards for CN and HCT respectively. The chromatography was achieved within 2.0 min run time using a C18 Phenomenex, Gemini NX (100 mm×4.6 mm, 5 µm) column with organic mixture:buffer solution (80:20, v/v) at a flow rate of 0.800 mL/min. The method has been successfully applied to establish the bioequivalence of candesartan cilexetil (CNC) and HCT immediate release tablets with reference product in human subjects.

Keywords: Bioequivalence; Candesartan cilexetil; Candesartan cilexetil-hydrochlorothiazide (ATACAND HCT); Hydrochlorothiazide; UPLC–MS/MS.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The product ion mass spectra of the [M−H]− ions of (A) IS1, (B) CN, (C) IS2 and (D) HCT.
Fig. 2
Fig. 2
Representative MRM chromatograms of blank plasma sample (A1 and A2), a plasma sample spiked with CN (B1) and HCT (B2) at the LLOQ level (1.00 ng/mL for both analytes) and a plasma sample from a healthy volunteer 1.5 h after the oral administration of the combination tablet. (C1 for CN and C2 for HCT). CN (left panels A1, B1 and C1) and its ISTD-CN d4 (right panels A1, B1and C1) and HCT (left panels A2, B2and C2) and its ISTD-HCT 13Cd2 (right panels A2, B2 and C2).
Fig. 3
Fig. 3
Mean plasma concentration–time curve for CN (A) and HCT (B) compared with standard (Atacand HCT®).
None
See this image and copyright information in PMC

References

    1. Gao F., Zhang Z., Bu H. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism. J. Controlled Release. 2011;149:168–174. - PubMed
    1. Flack J.M. Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide. Int. J. Clin. Pract. 2007;61:2093–2102. - PMC - PubMed
    1. Lee H.Y., Hong B.K., Chung W.J. Phase IV, 8-week, multicenter, randomized, active treatment–controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension. Clin. Ther. 2011;33:1043–1056. - PubMed
    1. Campbell M., Sonkodi S., Soucek M. A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy. Clin. Exp. Hypertens. 2001;23:345–355. - PubMed
    1. Bönner G., Fuchs W. Fixed combination of candesartan with hydrochlorothiazide in patients with severe primary hypertension. Curr. Med. Res. Opin. 2004;20:597–602. - PubMed

LinkOut - more resources